Answers are grounded in this paper and cite their sources.
Chemical modification plays a central role in optimizing siRNA therapeutics. Here, we designed and synthesized four amino-functionalized abasic phosphoramidite monomers (Ab1−Ab4) based on tetrahydropyrrole and aminocyclopentane scaffolds. Incorporation of these units destabilized siRNA duplexes in a position-dependent manner, and enhanced silencing activity at central or terminal positions on the sense strand, with the (S)-aminocyclopentane abasic (Ab4) exhibiting the strongest potency. Seed-region incorporation, particularly of the (R)-aminocyclopentane abasic (Ab3), mitigated miRNA-like off-target effects while retaining on-target activity in vitro. Following subcutaneous administration in mice, an Ab4-modified siRNA induced more potent hepatic mRNA knockdown than the parent siRNA at a single dose of 0.1 mg/kg, and Ab3 incorporation significantly reduced the number of off-target transcripts. In addition, 3′-terminal Ab4 incorporation improved nuclease resistance, leading to enhanced hepatic exposure in vivo, and served as a practical linker for conjugation. These findings establish amino-functionalized abasic units as a versatile platform for siRNA modification.
No takes yet. Share an insight, caveat, or question.
Zhong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: